Author: PROVIDENCE MEDICAL TECHNOLOGY

First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine

March 19, 2026
Providence Medical Technology Appoints Industry Veteran Jim Hens as Chief Commercial Officer as the Company Continues Rapid Growth Following Publication of Landmark Study

March 4, 2026

First Subjects Randomized in Clinical Trial Evaluating the Benefits of Total Segmental Fusion in Treating Degenerative Conditions in the Lumbar Spine